Overview
Jinju Park practices in Seoul, Republic of Korea. Park is rated as an Advanced expert by MediFind in the treatment of Rhabdomyosarcoma. Their top areas of expertise are Rhabdomyosarcoma, Cerebral Hypoxia, Stomach Cancer, and Diffuse Midline Glioma H3 K27M-Mutant.
Their clinical research consists of co-authoring 37 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 7 articles in the study of Rhabdomyosarcoma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- RhabdomyosarcomaPark isAdvanced. Learn about Rhabdomyosarcoma.
- Experienced
- Cerebral HypoxiaPark isExperienced. Learn about Cerebral Hypoxia.
- Diffuse Midline Glioma H3 K27M-Mutant
- GliomaPark isExperienced. Learn about Glioma.
- Gliomatosis CerebriPark isExperienced. Learn about Gliomatosis Cerebri.
- Stomach CancerPark isExperienced. Learn about Stomach Cancer.